What is the recommended management for hookworm infection?

Management of Hookworm Infection

For hookworm infection, treat with albendazole 400 mg orally daily for 3 days, which is the recommended first-line therapy based on current UK guidelines. 1

Diagnostic Confirmation

Before initiating treatment, confirm the diagnosis through:

• Concentrated stool microscopy or fecal PCR to identify hookworm eggs 1
• These tests can differentiate between Ancylostoma duodenale and Necator americanus, though treatment is the same for both species 1

First-Line Treatment Regimen

Albendazole 400 mg orally once daily for 3 days is the recommended treatment 1

Alternative Options (if albendazole unavailable):

• Mebendazole 500 mg as a single dose 1
• Ivermectin 200 μg/kg as a single dose 1

However, these alternatives are generally less effective than the 3-day albendazole regimen for hookworm specifically 1

Special Clinical Scenarios

Severe Disease with Anemia

• Add prednisolone 40-60 mg orally once daily in severe cases 1
• Seek specialist advice, as intensive care management may be needed 1
• Heavy infections commonly cause anemia, particularly in young children and women of childbearing age 1

Empirical Treatment for Eosinophilia

When hookworm is suspected but stool microscopy is negative (prepatent infection):

• Albendazole 400 mg single dose PLUS ivermectin 200 μg/kg single dose 1
• This combination covers possible prepatent geohelminth infections 1
• Critical caveat: Exclude Loa loa infection before giving ivermectin in patients who have traveled to endemic regions (Central/West Africa) 1

Loeffler's Syndrome (Pulmonary Manifestations)

If hookworm presents with larval migration through lungs (fever, urticaria, wheeze, dry cough):

• Treat the underlying hookworm infection as above 1
• Consider empirical treatment with ivermectin 200 μg/kg plus albendazole 400 mg if organism not identified 1
• Consider retreatment 1 month after resolution of pulmonary symptoms to ensure adult worms are treated 1
• Use steroids with extreme caution as they may cause hyperinfection if Strongyloides is present 1

Important Clinical Considerations

Treatment Efficacy Issues

• Recent research suggests that abnormal hemoglobin carriers (hemoglobin E, hemoglobin Constant Spring) may have poor response to albendazole 2
• If treatment failure occurs after two rounds of standard therapy, consider hemoglobin typing 2
• Pyrantel pamoate has shown resistance in some regions and should not be considered first-line 3

Pregnancy and Lactation

• Albendazole has very low levels excreted in breastmilk and is likely compatible with breastfeeding 1
• Consult specialist guidelines for pregnancy-specific recommendations 1

Pediatric Dosing

• For children >24 months: Use standard adult dosing 1
• For children 12-24 months: Discuss with an expert before treatment 1

Common Pitfalls to Avoid

1. Do not use single-dose albendazole 400 mg - this is less effective than the 3-day regimen for hookworm 1
2. Do not give ivermectin without excluding Loa loa in patients from endemic areas (risk of severe adverse reactions) 1
3. Do not assume treatment failure is due to resistance without considering host factors like abnormal hemoglobin 2
4. Do not use steroids empirically for pulmonary symptoms without excluding Strongyloides (risk of hyperinfection syndrome) 1

Follow-Up

• Repeat stool examination 14-21 days post-treatment to assess cure 4
• In endemic areas with ongoing exposure risk, periodic preventive chemotherapy may be needed 5, 6